GlassScriptPhysician profile
Sridevi Durga
NPI 1013175389
$8,806.40
in general payments reported to CMS, 2019-2025
43 companies · $1,074 in 2025
The $1,074 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,689 · 2020: $805 · 2021: $856 · 2022: $1,398 · 2023: $1,459 · 2024: $1,525 · 2025: $1,074.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,927 · Education: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,927.48 |
| Education | $130.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,026.51 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $895.25 | 2019-2025 | Farxiga, Lokelma, Brilinta |
| Amgen INC. | $791.54 | 2019-2025 | Repatha, Repatha |
| Philips North America LLC | $728.34 | 2019-2024 | (Br4) Coronary Undivided |
| Boehringer Ingelheim Pharmaceuticals, INC. | $670.61 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $639.80 | 2019-2025 | Avvigo Guidance System, Comet, Watchman Flx |
| Janssen Pharmaceuticals, INC | $468.51 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $457.19 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $369.26 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $305.94 | 2019-2025 | Lifevest |
| Asahi Intecc USA, INC. | $261.49 | 2019 | |
| Abiomed | $253.35 | 2019-2025 | |
| Kestra Medical Technology Services, INC. | $206.76 | 2023-2025 | Assure Wcd |
| Chiesi USA, INC. | $167.28 | 2022-2023 | Kengreal |
| Novo Nordisk INC | $158.03 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $138.57 | 2020-2025 | Diamondback Coronary, Emboshield Nav6 |
| Sanofi-Aventis U.S. LLC | $128.45 | 2019-2024 | |
| Shockwave Medical, INC | $116.79 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $99.73 | 2020-2022 | |
| Heartflow, INC. | $98.80 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $82.22 | 2022-2025 | Verquvo |
| Biobeat USA INC. | $81.65 | 2024 | Bb-613 Bpm Kit |
| Bayer Healthcare Pharmaceuticals INC. | $77.28 | 2023-2025 | |
| Amarin Pharma, INC. | $64.89 | 2019-2021 | |
| Grifols USA, LLC | $53.83 | 2023-2024 | Thrombate III |
| Medtronic, INC. | $52.38 | 2025 | Corevalve Evolut R |
| Memed US, INC. | $46.55 | 2024 | Memed Bv Calibrator |
| Stryker Corporation | $45.83 | 2025 | Clottriever Bold Catheter |
| Genzyme Corporation | $41.15 | 2024 | |
| Corcym INC | $33.08 | 2023 | Miami Instruments |
| Esperion Therapeutics, INC. | $29.28 | 2021-2025 | Nexletol |
| Scpharmaceuticals INC. | $23.14 | 2025 | |
| Zoll Circulation INC | $22.63 | 2025 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Lexicon Pharmaceuticals, INC. | $20.91 | 2023 | Inpefa |
| Actelion Pharmaceuticals US, INC. | $19.67 | 2019 | |
| Cordis US Corp. | $18.70 | 2024 | Angioguard |
| Kiniksa Pharmaceuticals International, Plc | $18.26 | 2024 | Arcalyst |
| Koya Medical, INC. | $18.05 | 2025 | Dayspring, Koya Medical |
| Daiichi Sankyo INC. | $17.76 | 2019 | |
| Ge Healthcare | $17.37 | 2022 | |
| Nipro Medical Corporation | $15.67 | 2025 | Hemodialysis System |
| Cardinal Health 200 LLC | $12.81 | 2020 | |
| Kls-Martin L.P. | $11.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sridevi Durga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.